Dr Allan Shelton Love, MD | |
12301 Snow Rd, Parma, OH 44130-1002 | |
(216) 524-7377 | |
(216) 265-4385 |
Full Name | Dr Allan Shelton Love |
---|---|
Gender | Male |
Speciality | Urology |
Location | 12301 Snow Rd, Parma, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326154915 | NPI | - | NPPES |
0935813 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 35-065048 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Allan Shelton Love, MD 1001 Lakeside Ave E, #1200, Cleveland, OH 44114-1158 Ph: () - | Dr Allan Shelton Love, MD 12301 Snow Rd, Parma, OH 44130-1002 Ph: (216) 524-7377 |
News Archive
Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why and determined how to make the nanoparticles effective against ovarian cancer cells.
Quanterix announced that it will release its financial results for first quarter 2019 after the close of trading on Thursday, May 9, 2019.
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.
Effective antiretroviral therapy has changed the human immunodeficiency virus (HIV) from a progressive, fatal disease to a chronic, manageable condition that is associated with higher rates of heart attacks, strokes, heart failure, sudden cardiac deaths, and other diseases compared to people without HIV, according to a new scientific statement from the American Heart Association published in the Association journal Circulation.
IOTA NanoSolutions Limited, a specialist formulation company, is pleased to announce today that it has completed a financing round to support the commercialisation of its proprietary nanodispersion formation technology, ContraSolâ„¢. New investor, QIB(UK) Plc joins Unilever Ventures Limited (UV) in this financing round.
› Verified 2 days ago
Dr. Walid Ibrahim Sidani, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-524-7377 Fax: 216-265-4385 | |
Dr. Paul Arthur Schefft Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-621-5600 Fax: 216-479-5554 |